Partner & Head of Public Equities at Catalio Capital Management
View Live Interactive Profile →Ben Snedeker is Partner and Head of Public Equities at Catalio Capital Management, LP. His firm biography states that he manages the firm's public equities portfolio across pharmaceuticals, biotechnology, medical devices, life science tools, diagnostics and data, and that he serves as Co-Head of Investments and sits on the Management Committee. He holds a B.S. in Chemistry from Pennsylvania State University and an M.S. in Chemistry from Yale University. He was previously Sector Head for Therapeutics at HealthCor Management and at PointState Capital, a therapeutics analyst and portfolio manager on the long-short healthcare equities team at D. E. Shaw & Co., and an Associate Principal in McKinsey & Company's Global Pharmaceuticals and Medical Products practice.